Adalimumab vs Aspirin

## Adalimumab vs Aspirin: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Aspirin**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Aspirin**: Irreversibly inhibits cyclooxygenase-1 and -2.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Aspirin — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Aspirin — C9H8O4.

**Molecular Weight**: Adalimumab — N/A; Aspirin — 180.1580 g/mol.

**Type**: Adalimumab — Antibody; Aspirin — Small molecule.